Multiple system atrophy: a clinical and neuropathological perspective
about
Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein AggregationGlia and alpha-synuclein in neurodegeneration: A complex interactionAnimal modeling an oligodendrogliopathy--multiple system atrophyNatural history of multiple system atrophy in the USA: a prospective cohort studyAlterations of eye movement control in neurodegenerative movement disorders.Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial.Mesenchymal stem cells can modulate longitudinal changes in cortical thickness and its related cognitive decline in patients with multiple system atrophy.Towards translational therapies for multiple system atrophyNovel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.Alpha-synuclein mRNA expression in oligodendrocytes in MSA.Preserved functional autonomic phenotype in adult mice overexpressing moderate levels of human alpha-synuclein in oligodendrocytes.Alpha-synuclein transfers from neurons to oligodendrocytes.Neuronal to oligodendroglial α-synuclein redistribution in a double transgenic model of multiple system atrophy.Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy.Models of multiple system atrophyOptimizing clinical trial design for multiple system atrophy: lessons from the rifampicin study.Review: Novel treatment strategies targeting alpha-synuclein in multiple system atrophy as a model of synucleinopathyExpanding the spectrum of neuronal pathology in multiple system atrophy.Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy.Neurodegenerative changes initiated by presynaptic dysfunction.Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophyExamining the mechanisms that link β-amyloid and α-synuclein pathologies.The role of glia in α-synucleinopathies.Cerebrospinal fluid biomarker candidates for parkinsonian disorders.Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system.Multiple system atrophy of the cerebellar type: clinical state of the art.Parkinson's disease: chameleons and mimics.Neuropathology of multiple system atrophy: new thoughts about pathogenesis.Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?Diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT: a clinical follow up study.Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.Multiple system atrophy: pathogenic mechanisms and biomarkers.Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology.Mitochondrial impairment and oxidative stress compromise autophagosomal degradation of α-synuclein in oligodendroglial cells.Potential Modes of Intercellular α-Synuclein Transmission.EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood.Intracellular alpha-synuclein affects early maturation of primary oligodendrocyte progenitor cellsMicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy.Preliminary report of multiple cell therapy for patients with multiple system atrophy.The neuropathology of multiple system atrophy and its therapeutic implications.
P2860
Q26771536-B4B5DB65-4745-47CC-A2DB-5F66AE8C1F24Q26851153-F7E67CFD-02B3-44EE-A6AE-62F47E95AFDCQ28074659-EB693E3B-E981-4956-8EF7-359454BCF52EQ30279265-864659C9-66DC-47F4-BFE6-505D68E6F3C8Q30436300-2BA0F826-5FBE-4AAA-8874-C8C0F80732D3Q33649211-51E825CA-3964-4969-B39F-E6DC99703CF8Q33750881-21DA8D7C-7583-4065-B614-17D434CE7FD8Q33797532-C86BC6B2-4867-4AE6-AC57-431D5A51A3EBQ33805560-490C1607-E703-4F44-89DD-4C09216C6E21Q34548507-976AFBEA-EC10-4731-8C57-2B32BC1CD653Q34631931-105667D2-DBE6-484D-8770-C1F11F096BC4Q35079415-627803FE-76E7-4259-8CC0-B6FDCDD94E37Q35786733-5C7296BF-EC04-4E72-A7E1-6ABBDA5E6E1EQ36341144-B8836B3A-DE66-4819-ABA4-0DF744C3923DQ36513407-DB5784D2-3BB0-4471-997F-CAFAEA60C5EBQ36607225-8EBB2F42-DB35-4484-9F7D-13A931D67C95Q36672116-875640DD-96F5-495C-8BB6-E1A490513991Q36825501-0B4F1BE2-7C8E-4D22-939E-81F3ECE90DACQ37092530-735382A8-5A81-4D44-B665-FBCE245FD42CQ37112980-6E0198C3-18B1-48EF-90D3-47A678375C6CQ37565960-C1C8A208-F8A6-48A7-A403-AA2C1090DDEAQ38006559-5A75280B-908E-4739-AC4F-1C86745E912EQ38039880-6000AB2E-895C-47A2-9FB4-5D6A6FE234F1Q38076411-5127C7CC-CB13-4B6A-A3E1-EA7138336C3AQ38098448-97876624-0B2F-4CE9-BF27-658389B45FAAQ38194974-F09D08B1-5598-4BD2-B6E0-29FA12C2D038Q38254117-2ED99631-CEC8-4A32-A7D4-EACCF7C07096Q38258246-827B3339-2F71-4B36-B8BF-7FEC76854DF5Q38475947-A440ED95-4C27-4959-A455-6FF5EE04611DQ38642358-A93CC1A4-691E-4B1B-9972-687BB893DA9FQ38669105-C0527DB2-DAC3-4747-B884-B352EBB047F6Q38813304-0400F00A-A722-4D51-B8D5-DDF54AB99E35Q38821003-0A49D6E1-91F0-4B88-877D-D18C7A928EC2Q38849169-23FBE0FE-30AC-42E9-B68C-AB7714F2D0F3Q39152836-94147475-EC07-463A-9579-F1A7EE0037F1Q39213724-B790F7A8-F5F9-4EC0-928F-252228B2D6B4Q42140713-E5BA4854-8A8D-4BC8-B551-3118E0A0DA0AQ44618765-E7E93937-ACB8-4258-A69B-58F2CDB5390DQ45281992-8CA8E2F4-4373-4DA6-9E27-827CC05DFD72Q45940520-C58D2446-9A53-42C1-86B1-F6BBF0D12405
P2860
Multiple system atrophy: a clinical and neuropathological perspective
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Multiple system atrophy: a clinical and neuropathological perspective
@ast
Multiple system atrophy: a clinical and neuropathological perspective
@en
Multiple system atrophy: a clinical and neuropathological perspective
@nl
type
label
Multiple system atrophy: a clinical and neuropathological perspective
@ast
Multiple system atrophy: a clinical and neuropathological perspective
@en
Multiple system atrophy: a clinical and neuropathological perspective
@nl
prefLabel
Multiple system atrophy: a clinical and neuropathological perspective
@ast
Multiple system atrophy: a clinical and neuropathological perspective
@en
Multiple system atrophy: a clinical and neuropathological perspective
@nl
P2860
P1476
Multiple system atrophy: a clinical and neuropathological perspective
@en
P2093
Phillip Low
P2860
P304
P356
10.1016/J.TINS.2011.08.003
P407
P577
2011-11-01T00:00:00Z